uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Zemfirza
Application withdrawn
Human
Details
EMA number
EMEA/H/C/004003
ATC code
L01XE32
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of platinum sensitive relapsed (PSR) ovarian cancer
MeSH:
Ovarian Neoplasms
Group:
Antineoplastic agents
Active substances
cediranib maleate
Marketing Authorisation Holder
AstraZeneca AB
MAH
Zemfirza | uMedical